News

  • H
    Healthcare
  • L
    LifeSciences
  • S
    Stability & Bio Storage
  • C
    Corporate

Holdings in Company

The attached TR1 notification relates to the shareholding in Source BioScience plc held by Spartan Fund Ltd which now stands at 21,677,490 shares, representing 6.21% of the Company’s ordinary share capital.

Trading Update

Source BioScience plc today announces an update on its trading performance for the year ended 31 December 2015.

Holdings in Company

The attached TR1 notification relates to the shareholding in Source BioScience plc held by Spartan Fund Ltd which now stands at 20,592,490 shares, representing 5.90% of the Company’s ordinary share capital

Sir Ranulph Fiennes to Launch the World’s First -70°C Walk-in Chamber

On the 3rd February, Source BioScience, the international laboratory services and products business, will celebrate the launch of its revolutionary -70°C walk-in chamber, the Polar 50.

Holdings in Company

The attached TR1 notification relates to the shareholding in Source BioScience plc held by Spartan Fund Ltd which now stands at 18,131,429 shares, representing 5.19% of the Company’s ordinary share capital.

Christmas Opening Times

Details of our opening times throughout the Christmas and New Year period.

Just Between Us™ sexual health service launches ST10 the home-sampling kit for 10 sexually transmitted infections

Source BioScience announces further enhancements to the Group’s Just Between Us™ online sexually transmitted infection (“STI”) testing service with the launch of ST10.